{
    "patient": {
        "Name": "Heather Ellison",
        "DateOfBirth": "1952-11-07",
        "Sex": "Male",
        "Diagnosis": "Pancreatic neuroendocrine tumors",
        "BodyPart": "Pancreatic",
        "Physician": "Dr. Hector Flores",
        "TreatingInstitution": "Jackson, Herrera and Anderson"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Pancreatic",
            "CollectedDate": "2023-12-09",
            "ReceivedDate": "2023-12-12",
            "TumorPercentage": "72%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2023-12-13",
            "ReceivedDate": "2023-12-16"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "BLM",
                "DNA Alteration": "c.2207_2212delinsTAGATTC",
                "GeneMutation": "p.Y736fs*4 Spliceregionvariant-GOF",
                "VariantAlleleFraction": "19.6%"
            },
            {
                "Gene": "NCSTN",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.A572G Stopgain-LOF",
                "VariantAlleleFraction": "23.45%"
            },
            {
                "Gene": "NCSTN",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.A572G Spliceregionvariant-LOF",
                "VariantAlleleFraction": "25.26%"
            },
            {
                "Gene": "FLT3",
                "DNA Alteration": "c.1775T>G",
                "GeneMutation": "p.V592A Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "4.84%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "MYOD1",
                "DNA Alteration": "c.365T>G",
                "GeneMutation": "p.V592G Frameshift-LOF",
                "VariantAlleleFraction": "10.31%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "SIX1",
            "FGFR3"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "31 m/Mb",
            "Tmbpercentile": "49%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "Stable"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}